NCT05679193 2024-05-29
PeP-RALP
Oslo University Hospital
Phase 2 Completed
Clinical Trials
15 trialsNCT02641314 2024-05-10
METRO-NB2012
University of Cologne
Phase 2 Completed
NCT04518124 2023-11-22
Propranolol in Angiosarcoma
The Netherlands Cancer Institute
Phase 2 Completed
NCT05327309 2023-09-13
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
Shaheed Zulfiqar Ali Bhutto Medical University
Phase NA Completed
NCT02342275 2022-06-16
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
West China Hospital
Phase 3 Completed
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT01847001 2021-09-10
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Columbia University
Phase 2 Completed
NCT02420223 2021-06-07
Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients
Medical College of Wisconsin
Phase 2 Completed
NCT02505971 2020-10-28
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
The Hospital for Sick Children
Phase 3 Completed
NCT01504126 2019-08-29
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01908972 2018-12-19
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
Seoul National University Hospital
Phase 4 Completed
NCT02104011 2018-01-23
STBETA
University Hospital, Bordeaux
Phase 2 Completed
NCT01308944 2017-01-12
Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Washington University School of Medicine
Phase 1 Completed
NCT01072045 2014-12-02
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo
Phase 2 Completed
NCT01211080 2014-11-11
PIHS
Hannover Medical School
Completed